These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11796814)

  • 1. What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey.
    Klein SJ; Harris-Valente K; Candelas AR; Radigan M; Narcisse-Pean M; Tesoriero JM; Birkhead GS
    J Urban Health; 2001 Dec; 78(4):679-89. PubMed ID: 11796814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanding access to sterile syringes through pharmacies: assessment of New York's Expanded Syringe Access Program.
    Tesoriero JM; Battles HB; Klein SJ; Kaufman E; Birkhead GS
    J Am Pharm Assoc (2003); 2009; 49(3):407-16. PubMed ID: 19443321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
    Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users.
    Coffin PO; Ahern J; Dorris S; Stevenson L; Fuller C; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S62-7. PubMed ID: 12489618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation.
    Linas BP; Coffin PO; Backes G; Vlahov D
    J Urban Health; 2000 Dec; 77(4):768-80. PubMed ID: 11194316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringe disposal among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.
    Cleland CM; Deren S; Fuller CM; Blaney S; McMahon JM; Tortu S; Des Jarlais DC; Vlahov D
    Health Educ Behav; 2007 Apr; 34(2):390-403. PubMed ID: 16816027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002).
    Finkelstein R; Tiger R; Greenwald R; Mukherjee R
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S83-7. PubMed ID: 12489622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of nonprescription syringe sales in San Francisco.
    Rose VJ; Raymond HF
    J Am Pharm Assoc (2003); 2010; 50(5):595-9. PubMed ID: 20833617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual- and neighborhood-level factors associated with nonprescription counseling in pharmacies participating in the New York State Expanded Syringe Access Program.
    Rivera AV; Blaney S; Crawford ND; White K; Stern RJ; Amesty S; Fuller C
    J Am Pharm Assoc (2003); 2010; 50(5):580-7. PubMed ID: 20833615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.
    Coffin PO; Fuller C; Blaney S; Vadnai L; Miller S; Vlahov D
    Clin Infect Dis; 2004 Feb; 38(3):438-41. PubMed ID: 14727219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings.
    Deren S; Cleland CM; Fuller C; Kang SY; Des Jarlais DC; Vlahov D
    AIDS Behav; 2006 Nov; 10(6):717-21. PubMed ID: 16642418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.
    Deibert RJ; Goldbaum G; Parker TR; Hagan H; Marks R; Hanrahan M; Thiede H
    Am J Public Health; 2006 Aug; 96(8):1347-53. PubMed ID: 16809607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who purchases nonprescription syringes? Characterizing customers of the Expanded Syringe Access Program (ESAP).
    Battles HB; Rowe KA; Ortega-Peluso C; Klein SJ; Tesoriero JM
    J Urban Health; 2009 Nov; 86(6):946-50. PubMed ID: 19434499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.
    Gleghorn AA; Gee G; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000-2001.
    Des Jarlais DC; McKnight C; Friedmann P
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S73-6. PubMed ID: 12489620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual- and neighborhood-level characteristics associated with support of in-pharmacy vaccination among ESAP-registered pharmacies: pharmacists' role in reducing racial/ethnic disparities in influenza vaccinations in New York City.
    Crawford ND; Blaney S; Amesty S; Rivera AV; Turner AK; Ompad DC; Fuller CM
    J Urban Health; 2011 Feb; 88(1):176-85. PubMed ID: 21279450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.